About Clinical Ink
Clinical Ink is a company based in Winston-salem (United States) founded in 2006 was acquired by GI Partners in August 2020. Clinical Ink has raised $13.15 million across 8 funding rounds from investors including SVB, GI Partners and RTI International. Clinical Ink has completed 1 acquisition, including Digital Artefacts. Clinical Ink offers products and services including eCOA, Direct Data Capture, and eConsent. Clinical Ink operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Winston-salem, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinical Ink
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.15 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
SVB
& 8 more
-
Employee Count
Not available
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinical Ink
Clinical Ink offers a comprehensive portfolio of products and services, including eCOA, Direct Data Capture, and eConsent.
Platform for capturing and managing clinical trial outcomes electronically.
Software to validate real-time data from trials and devices.
System for simplifying electronic consent in clinical studies.
People of Clinical Ink
Unlock access to complete
Unlock access to complete
Software Development Team
22 people
Project Team
14 people
Leadership Team
11 people
Data Analysis and Operations Team
9 people
Creative and Marketing Team
5 people
Advisor Team
4 people
Product Management Team
4 people
Senior Team
4 people
Unlock access to complete
Funding Insights of Clinical Ink
Clinical Ink has successfully raised a total of $13.15M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Clinical Ink
Clinical Ink has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, GI Partners and RTI International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech-focused venture capital firm investing primarily in the US
|
Locked | Locked | Locked | |
|
VC investments are handled by the McWhorter family office.
|
Locked | Locked | Locked | |
|
Offline-focused VC firm investing primarily in the US
|
Locked | Locked | Locked |
Investor details for Clinical Ink
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clinical Ink
Clinical Ink has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Digital Artefacts.
Investment portfolio details for Clinical Ink
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of the clinical trial management platform
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Clinical Ink
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Clinical Ink
Detailed financials for Clinical Ink
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinical Ink Comparisons
Peer comparison for Clinical Ink
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clinical Ink
Clinical Ink operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of Clinical Ink
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinical Ink
Complete news archive for Clinical Ink
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinical Ink
Clinical Ink was founded in 2006.
Clinical Ink is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Jonathan Goldman is the current CEO of Clinical Ink.
Clinical Ink is a funded company, having raised a total of $13.15M across 8 funding rounds to date.
Clinical Ink was founded in 2006 and is headquartered in Winston-Salem, United States. eSource solutions are offered through the SureSource platform, which enables electronic capture of data and documents at clinical trial sites. The CentrosHealth platform supports patient engagement via configurable apps to maintain involvement and compliance. Services target pharmaceutical companies, medical device firms, academic institutions, and contract research organizations in the global clinical trials sector.
Clinical Ink offers eCOA, Direct Data Capture, and eConsent.
Clinical Ink has made 1 acquisition, including Digital Artefacts.
Clinical Ink has 9 investors. Key investors include SVB, GI Partners, RTI International, SLR Investment Corp, and Dioko Ventures.